DMXL2: A Potential Drug Target for Neurological Disorders (G23312)

Target Name: DMXL2

NCBI ID: G23312

DMXL2

DMXL2: A Potential Drug Target for Neurological Disorders

DMXL2 (doublecortin) is a protein that is expressed in the brain and is known for its role in the development and progression of several neurological disorders, including Alzheimer's disease. It is also a potential drug target (or biomarker) for the treatment of these disorders.

DMXL2 is a member of the T-cell signaling pathway, which is a critical pathway for the development and maintenance of the immune system. It is expressed in various tissues and cells, including the brain, and has been shown to play a role in the development and progression of several neurological disorders, including Alzheimer's disease.

One of the key functions of DMXL2 is its role in the regulation of the immune system. It has been shown to modulate the immune response and to play a role in the regulation of immune cell function. This is important because alterations in the immune system have been implicated in the development and progression of several neurological disorders, including Alzheimer's disease.

In addition to its role in the immune system, DMXL2 is also involved in the regulation of cell survival and metabolism. It has been shown to play a role in the regulation of cell survival and to promote the growth and survival of certain cells. This is important because changes in cell survival and metabolism have been implicated in the development and progression of several neurological disorders, including Alzheimer's disease.

DMXL2 is also involved in the regulation of inflammation. It has been shown to play a role in the regulation of inflammatory responses and to promote the regulation of inflammation. This is important because changes in inflammation have been implicated in the development and progression of several neurological disorders, including Alzheimer's disease.

In conclusion, DMXL2 is a protein that is expressed in the brain and is known for its role in the development and progression of several neurological disorders, including Alzheimer's disease. It is also a potential drug target (or biomarker) for the treatment of these disorders. Further research is needed to fully understand the role of DMXL2 in the development and progression of these disorders and to develop effective treatments.

Protein Name: Dmx Like 2

Functions: May serve as a scaffold protein for MADD and RAB3GA on synaptic vesicles (PubMed:11809763). Plays a role in the brain as a key controller of neuronal and endocrine homeostatic processes (By similarity)

The "DMXL2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DMXL2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets